Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FiberUs
- Development stage
- Unknown
- Lead developer
- Morphus
- Administration
- Oral
01
Overview
FiberUs is an unflavored soluble prebiotic fiber supplement developed and marketed by Morphus, specifically formulated for women in perimenopause and menopause. The product is composed of partially hydrolyzed guar fiber (guar gum), which provides 6.5 grams of fiber per serving. It is designed to support digestive health by alleviating occasional gas, bloating, constipation, and diarrhea without causing the excessive fermentation often associated with other fiber types. As a prebiotic, it helps maintain a healthy gut microbiome and improves the movement of food through the digestive tract.
- Brand names
- FiberUs
- Other names
- guar fiberpartially hydrolyzed guar gumPHGG
Beyond the preview
Go deeper on FiberUs.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FiberUs.